Using multicolor immunohistochemistry, we demonstrated that protein expression levels of IGFBP2 as well as its selective ligands IGF1 and IGF2 were significantly downregulated in AEC2 cells of the lung disease groups compared with healthy controls. This evidence concerns the gene IGFBP2 and lung disorder.